Spectranetics, Medtronic settle intellectual property suit Spectranetics says Medtronic licenses disputed patent, companies reach settlement April 28, 2008: 08:41 AM EST
NEW YORK (Associated Press) - Spectranetics Corp. said Monday it has settled its intellectual property dispute with Medtronic, with Medtronic licensing the patent at issue.
Terms of the settlement agreement were not disclosed.
Spectranetics' disposable catheters use high-energy ultraviolet light to vaporize artery blockages in the legs and heart, as well as scar tissue surrounding pacing and defibrillation leads. Top of page
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.